Related by context. All words. (Click for frequent words.) 89 Completes Patient Enrollment 88 Initiates Clinical Trial 88 Files IND 88 Initiates Phase II 87 Submits NDA 87 Receives Approvable Letter 86 Drug Candidate 86 Receives Milestone Payment 86 Completes Enrollment 86 Initiates Enrollment 86 Presents Preclinical Data 85 Meets Primary Endpoint 85 Initiates Phase III 85 Presents Positive 85 Initiates Clinical 85 FDA Accepts 84 Receives Positive Opinion 84 Granted Orphan Drug 84 Demonstrates Significant 84 Receives Orphan Drug 83 Phase 2b Clinical Trial 83 FDA Clears 83 Receives FDA Clearance 83 Announces FDA Clearance 83 Submits Biologics License Application 83 Novel Oral 83 Begins Dosing 82 Receives Fast Track 82 Gets FDA Clearance 82 Patient Enrollment 82 Phase IIb Trial 82 Announce License Agreement 82 Present Preclinical Data 81 Phase IIb Clinical Trial 81 Successfully Completes Phase 81 Initiates Clinical Trials 81 Initiates Phase 81 Phase 2a Trial 81 Study Evaluating 81 Prolongs Survival 81 Enrolls First 81 Announces Tentative Approval 81 Achieves Primary Endpoint 81 Fast Track Status 81 Submits IND 81 Submits Response 81 Phase 2b Trial 81 Licenses Novel 81 FDA Approvals 81 Mylan Receives Approval 81 Files Investigational 81 Clinical Trial Evaluating 81 Phase III Clinical Trial 81 Phase III Trial 81 BioSante Pharmaceuticals Announces 81 Presents Preclinical 81 Clinical Trial Results 81 Investigational Compound 81 Expanded Indication 81 Investigational Treatment 80 Patients Treated With 80 Psoriasis Drug 80 Initiate Clinical Trial 80 Improves Survival 80 Preclinical Data 80 NDA Submission 80 Reports Preclinical Data 80 Vaccine Adjuvant 80 Drug Fails 80 PRN FDA Approves 80 Develop Novel 80 Reveals Positive 80 Vitrasert R 79 Therapeutic Competitors Companies 79 Single Dose 79 FDA Approves 79 Commences Phase 79 Initiates Dosing 79 Initiates Phase 2b 79 Pivotal Study 79 Pivotal Phase III 79 Initiate Phase 79 Submits Application 79 Demonstrates Positive 79 Sign Licensing Agreement 79 Patent Covering 79 Teva Provides Update 79 Initiate Phase III 79 Kinase Inhibitor 79 FDA APPROVES 79 Receives Complete Response 79 Generic Version 79 Phase 2a Clinical Trial 79 Tezampanel 79 FDA Okays 79 Submits Supplemental 79 Earns Milestone Payment 79 Announces Initiation 79 Announces Poster Presentations 79 Lung Cancer Drug 79 Receives Tentative Approval 79 Taro Receives 79 Drug Shows Promise 79 Demonstrates Potential 79 JAK2 Inhibitor 79 Combination REOLYSIN R 78 IND Application 78 Previously Treated 78 Trial Evaluating 78 Investigational Oral 78 Transdermal Patch 78 Shows Promise 78 Protease Inhibitor 78 Phase IIa Clinical Trial 78 Shows Promising 78 pralatrexate injection folate analogue 78 Prostate Cancer Vaccine 78 Recombinant Human 78 Adjuvant Treatment 78 Launches Generic Version 78 Severe Sepsis 78 Lupus Drug 78 Hsp# Inhibitor 78 Receive Milestone Payment 78 Oral Fingolimod 78 Presents Positive Preclinical 78 Improves Outcomes 78 Advanced Melanoma 78 Rheumatoid Arthritis Drug 77 Significantly Improves 77 Antitumor Activity 77 Announce Collaboration Agreement 77 Files Patent Application 77 Arthritis Drug 77 Receives Marketing Authorization 77 Personalized Immunotherapy 77 First Patient Enrolled 77 Monoclonal Antibody 77 RNAi Therapeutic 77 Milestone Payment 77 II Clinical Trial 77 Pivotal Trial 77 IND Filing 77 Oral Calcitonin 77 Receives Patent 77 Announces License Agreement 77 Receives CE Marking 77 Announce Initiation 77 Dose Ranging Study 77 Cholesterol Lowering Drug 77 Orally Active 77 First Patient Dosed 77 Generic Versions 77 Migraine Drug 77 Study Demonstrates 77 Receives SFDA Approval 77 Patent Issued 77 Immunomedics Announces 77 Phase 1b Clinical Trial 77 Complicated Skin 77 Sign License Agreement 77 vapreotide acetate 76 Epilepsy Drug 76 Shows Promise Against 76 Investigational Drug 76 Systemic Delivery 76 First Patient Treated 76 Positive Opinion 76 candidates Azedra TM 76 Significantly Reduces 76 Adjunctive Therapy 76 Obtains License 76 Gout Drug 76 Pivotal Phase 76 Treatment Naïve 76 Completes Dosing 76 Hematological Malignancies 76 sapropterin dihydrochloride 76 Shows Efficacy 76 Small Molecule 76 Osteoporosis Drug 76 Combination Treatment 76 Anti Tumor 76 Crofelemer budesonide foam 76 Achieves Milestone 76 FOLOTYN ® 76 Collaborators Publish 76 acetonide FA 76 Begins Shipment 76 Announces Presentation 76 Phase III Trials 76 Announces Positive 76 Grants Orphan Drug 76 Collaborators Present 76 Proven Effective 75 Chronic Hepatitis C 75 Therapeutic Competitors Report 75 Receives Clearance 75 Orphan Status 75 Aztreonam Lysine 75 Confirms Efficacy 75 Vascular Disrupting Agent 75 Patients Treated 75 Pooled Analysis 75 Tumor Targeting 75 Shows Statistically Significant 75 methylnaltrexone bromide 75 Long Term Efficacy 75 TO AVOID PREGNANCY WHILE 75 Novel Antibiotic 75 Tyrosine Kinase Inhibitor 75 Well Tolerated 75 markets HP Acthar 75 Patients Suffering 75 Successfully Treats 75 TRANSDUR ® 75 Patients Enrolled 75 Xcytrin R 75 Demonstrates Efficacy 75 Blood Pressure Drug 75 Phase 2b Study 75 Reduces Risk 75 platform HDL Mimetic 75 Completes Patient Enrolment 75 Commercialize 75 Begin Clinical Trials 75 Molecular Diagnostic Test 75 Refractory Hodgkin Lymphoma 75 Study Showed 75 Receives Favorable 75 Announces Licensing Agreement 75 Mg Usa 75 Mouse Model 75 Humanized Anti 75 Provides Update Regarding 75 Therapeutic Competitors companiesandmarkets.com adEgemonye 75 Schizophrenia Drug 75 Obtains FDA 75 Announce Merger Agreement 75 Antibody Drug Conjugate 75 R lenalidomide 75 JAK Inhibitor 75 Newly Diagnosed Multiple Myeloma 75 Bazedoxifene 75 Spectrum Pharmaceuticals Announces 75 Aloxi ® 75 Reports Positive 75 Announce Licensing Agreement 75 developing Bicifadine serotonin 75 Survival Benefit 75 Commence Phase 75 Awarded Patent 75 Zorbtive TM 75 lead molecular radiotherapeutic 75 Clinical Study Shows 75 Combination Therapy 74 Diabetic Neuropathy 74 Novel Compound 74 Namenda Memantine HCl 74 Confirmatory Phase 74 Patient Enrolment 74 Recommends Approval 74 R Saizen R 74 Pivotal Clinical Trial 74 ODT metoclopramide HCl PEPCID 74 Reacquires 74 Receives Approval 74 Sagent Pharmaceuticals Announces 74 Million Milestone Payment 74 molecular imaging radiopharmaceutical 74 Announces Publication 74 Plaque Psoriasis 74 Receives Positive 74 Receives CE 74 FDA Clearance 74 Nasdaq VNDA 74 Anticancer Drug 74 Treatment Resistant 74 Demonstrates Sustained 74 AUDIO PROVIDED BY 74 Metastatic Melanoma 74 Cutaneous T 74 interferon beta 1a infertility 74 Hormone Refractory Prostate Cancer 74 Acute Attacks 74 Telik logo TELINTRA 74 Proves Effective 74 Awarded Qualifying Therapeutic 74 Generic Version Of 74 SABER ™ 74 Cypher Sirolimus 74 Pafuramidine 74 Commercialize Novel 74 HCV Protease Inhibitor 74 HER2 Positive 74 Oral Mucositis 74 lexidronam injection 74 Pegloticase 74 Abstract Accepted 74 RNAi Therapeutics 74 Immunotherapeutic 74 Preclinical Study 74 essential thrombocythemia ET 74 Investigational Agent 74 Therapeutic Vaccine 74 Peginterferon alfa 2b 74 Romiplostim 74 Effectively Treats 74 Bosutinib 74 Slow Progression 74 candidates Azedra 74 k Clearance 74 Cholesterol Drug 74 Fungal Infections 74 non nucleoside inhibitor 74 TRANSDUR ™ 74 Inc Therapeutic Competitors 74 Data Suggest 74 Disease Modifying 74 Pharma Merck Serono 74 Inhalation Aerosol 74 Signs License Agreement 74 VIVITROL ® 74 TM Aganocide 74 Chronic Hepatitis B 74 Anti Tumor Activity 74 Patients Receiving 74 Slows Progression 74 Extends Collaboration 74 Rotavirus Vaccine 74 Obtains Approval 74 Acquires Exclusive 74 Ovitrelle R Serostim 74 Wafer polifeprosan 73 Cites Positive 73 Is Well Tolerated 73 Receptor Agonist 73 Successfully Treated 73 Settle Patent Litigation 73 Anticancer Compound 73 PEGylated Fab fragment 73 Supplemental Biologics License Application 73 Novel Inhibitor 73 IG HCR ;) CO 73 Identifies Potential 73 oncolytic virus therapies 73 Previously Untreated 73 Node Positive 73 Interferon Alpha 73 Medoxomil 73 gets USFDA nod 73 Expand Collaboration 73 Low Dose 73 Nasdaq XTLB 73 AVI BioPharma Announces 73 Vicriviroc 73 ALN HPN 73 Seasonal Influenza Vaccine 73 evaluating picoplatin 73 CHEAP ONLINE PHARMACY LOW 73 Antigen Specific 73 Nicotine Vaccine 73 Osteoporosis Treatment 73 topically applied SEPA 73 Pulmonary Arterial Hypertension 73 Treatment Experienced 73 Mg Uk 73 novel emulsion formulation 73 Lowers Risk 73 HDAC Inhibitor 73 Amends Agreement 73 Inhaled Insulin 73 Desvenlafaxine 73 Receives NASDAQ 73 ORLive Presents 73 Inhibits 73 Vitrasert ® 73 ELADUR TM 73 5q MDS 73 Renal Cell Carcinoma 73 Issued Patent 73 Polymerase Inhibitor 73 Treatment Reduces 73 Augment TM 73 Oral Formulation 73 Hepatitis B Vaccine 73 Testosterone Gel 73 Jumps Higher 73 GTC recombinant form 73 Gonal f R follitropin 73 NICE Recommends 73 THERAPEUTICS 73 Transdermal System 73 R famotidine 73 Friedreich Ataxia FRDA 73 R MSCRAMM 73 Demonstrates Statistically Significant 73 SPL# Gel vaginal microbicide 73 AAG geldanamycin analog 73 COMUNICADO 73 Febuxostat 73 targeted radiotherapeutic 73 Lanthanum Carbonate 73 Awarded Patents 73 Flagship Product 73 diarrhea fatigue asthenia 73 Agonist MABA program 73 REPRONEX R menotropins 73 balsalazide disodium Capsules 73 refractory chronic lymphocytic 73 induced macular edema 73 Milestone Payments 73 Safinamide 73 Granulocyte Colony Stimulating Factor 73 Inc. Nasdaq OXGN 73 TNF Blockers 73 Metabolic Disorder 73 Cell Transplants 73 Adjuvant Chemotherapy 73 Hypertensive Patients 73 SPRYCEL ® 73 Receives Notification 73 VentiRx Pharmaceuticals 73 Relapsed Refractory 73 R bisoprolol Euthyrox 73 Pruvel TM 73 HER2 Positive Breast Cancer 73 Phase IIa Trial 73 CysDisplay R 73 Announces Successful Completion 73 AnaSpec Introduces 73 IN PATIENTS WITH 73 Initiate Phase II 73 STERIS Corporation Announces 73 Adjuvant Therapy 73 oropharyngeal candidiasis OPC 73 Improved Survival 73 Soft Tissue Sarcoma 73 submitted Biologics License 73 Demonstrates Potent 73 PDUFA Date 73 By JAMAAL ABDUL 73 investigational oral inhibitor 73 Receptor Antagonist 73 NicVAX TM 73 MOVIPREP R 73 Regains NASDAQ 73 Vaccine Candidate 73 Randomized Double Blind 73 Combo Therapy 73 Milestone Payment From 73 Efficacy Results 73 Flamel Technologies Announces 73 Dose Escalation 72 Expands Scientific Advisory 72 markets COLAZAL 72 COLAZAL R 72 Patients Undergoing 72 Merck OSI Pharmaceuticals 72 Glatiramer Acetate 72 Aflibercept 72 Submits Investigational 72 Ondansetron Orally Disintegrating Tablets 72 Intravenous Formulation 72 Appears Safe 72 Gel repository corticotropin injection 72 Melphalan 72 Telaprevir VX 72 Drug Resistant 72 liver resection surgeries 72 Serostim ® 72 Myeloma Patients 72 ABLYNX 72 Kuvan TM sapropterin 72 Significantly Improved 72 pan histone deacetylase 72 Obtains Exclusive License 72 Novel Therapeutic 72 oral prodrug 72 Significantly Increases 72 COLLABORATION WITH 72 Trobalt 72 Pharmacokinetic Study 72 Antifungal 72 Provides Guidance 72 topical gel formulation 72 Lupus Nephritis 72 please visit http:/www.vandapharma.com 72 delivers fluocinolone acetonide FA 72 Regenerative Cells 72 C1 Inhibitor 72 Antitumor 72 cardiometabolic diseases Glucophage 72 Announcement acc 72 lexidronam injection PROSTASCINT 72 TNF Tumor Necrosis Factor 72 Elderly Patients 72 Prospective Randomized 72 Taglich Brothers Initiates Coverage 72 COLAZAL ® 72 NASH Huntington 72 Issues Guidance 72 XL# anticancer compounds 72 Efficacy Trial 72 Doripenem 72 Announces Issuance 72 Eluting Stent 72 Blood Thinner 72 Announces Immediate Availability 72 Kuvan R 72 Receives Tentative FDA 72 Ecallantide 72 PHASE III 72 Phase III Clinical Trials 72 5 FU leucovorin 72 Commences Phase III 72 Hydrochlorothiazide Tablets 72 VIVUS Announces 72 ATRA IV 72 Preclinical Models 72 Mycophenolate Mofetil 72 Oral Solution OSMOPREP 72 Controlled Study 72 Significantly Reduced 72 Sangamo BioSciences Announces 72 Vascular Grafts 72 BioElectronics Announces 72 Randomized Study 72 Luveris R Ovidrel R 72 Patents Covering 72 PROVENGE ® 72 Attenuates 72 Application MAA 72 FUSILEV ® 72 Signs Licensing Agreement 72 IMiDs ® 72 Receives Regulatory 72 erlotinib Tarceva R 72 Randomized Phase 72 Resubmits 72 Dry Powder Inhaler 72 Prodrug 72 SYCREST 72 product platforms AZX# 72 Relapsing Multiple Sclerosis 72 Patient Treated 72 Myelodysplastic Syndromes 72 Pivotal Trials 72 dasatinib Sprycel ® 72 Monotherapy 72 Strengthens Position 72 Hematology Molecular Pathology 72 R bendamustine hydrochloride 72 Ceflatonin R 72 PROCTOCORT R 72 PNP inhibitor 72 Announce Collaboration 72 Multiple Ascending Dose 72 dependent kinase inhibitor 72 R metformin Concor 72 PROSTASCINT R 72 novel orally inhaled 72 DIURIL R 72 Genotyping Test 72 By JENNIFER LEARN 72 benzoic acid hyoscyamine sulfate 72 CE marked PROGENSA 72 Topical Treatment 72 Renal Cancer 72 Inhaled Corticosteroids 72 Conjugate 72 Improve Survival 72 FDA Approves Drug 72 FDA Panel Recommends 72 Anticancer Activity 72 Metastatic Colorectal Cancer 72 Tumor Growth 72 Phase III Pivotal 72 Licenses Patents 72 NEUPOGEN R 72 Vidaza R 72 release capsules FENTORA 72 Microwave Ablation System 72 Sinks Lower 72 Voluntarily Withdraw 72 Novel Treatments 72 selective A2A adenosine receptor 72 Iluvien ® 72 Benign Prostatic Hyperplasia 72 Atypical Antipsychotic 72 Fondaparinux 72 Unigene nasal calcitonin 72 Brentuximab Vedotin SGN 72 Receives Conditional 72 injectable bulking agent 72 Anti Inflammatory 72 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 72 HCl Injection 72 Aurora Kinase 72 myelodysplastic myeloproliferative diseases 72 Anticancer Agent 72 Vaccine Protects Against 72 ELADUR ™ 72 Files Shelf Registration Statement 72 DNA methyltransferase inhibitors 72 BCG refractory carcinoma 71 INSPIRE Trial Phase III 71 Demonstrates Ability 71 humanized therapeutic 71 Clinical Trial Data 71 PEGylated anti 71 SIDE EFFECTS CHEAP ONLINE 71 Ridaforolimus 71 developing Zerenex ferric 71 Fixed Dose 71 Treated Patients 71 Potassium Chloride Sodium Ascorbate 71 Am J Obstet 71 Vitro Activity 71 Inhalation Solution 71 TRACON Pharmaceuticals 71 Liprotamase 71 highly purified pasteurized 71 MKC# 71 Oral Spray 71 DOXIL R 71 COMUNICADO DE 71 Oral Suspension USP 71 Release Capsules 71 Therapeutic Antibody 71 Neulasta R 71 2 methoxyestradiol 71 Oral Cladribine 71 Oral Suspension Oral Suspension 71 Elagolix 71 Receives Notice 71 Fludara ® 71 Prostate Cancer Patients 71 Clinical Study 71 Develops Novel 71 Biomarker Study 71 SIX RO ROG 71 Accelerate Commercialization 71 Civacir 71 Genentech sanofi aventis 71 Hepatocellular Carcinoma 71 Randomized Phase II 71 corticotropin injection 71 Alvine Pharmaceuticals 71 Orphan Drug Status 71 Files Patent 71 Regains Full 71 Advanced Renal Cell 71 Xeloda ® 71 Shown Effective 71 Novel Mechanism 71 Novartis Novo Nordisk 71 beta 1a 71 Unfractionated Heparin 71 abacavir sulfate lamivudine 71 Amigal TM 71 Reduces Mortality 71 Introduces Novel 71 MEK Inhibitor 71 STELARA TM 71 Resubmission 71 Biogen Genentech 71 GATTEX TM 71 Secures Financing 71 CYT# potent vascular disrupting 71 NOTE POSIDUR ™ 71 Drug Combo 71 Colaris Colaris AP 71 Desvenlafaxine Succinate 71 CHEAP ONLINE PHARMACY BEST 71 FDA Approves Generic 71 Rheumatoid Arthritis Patients 71 Microplasmin 71 Increases Risk 71 vinorelbine tartrate 71 Oral Insulin 71 sarcoma melanoma 71 Synthetic Peptide 71 Test Detects 71 Epratuzumab 71 Enrolling Patients 71 OMAPRO ™ 71 VISICOL R 71 HuCAL PLATINUM ® CysDisplay 71 topical non steroidal 71 Intravenous Human 71 Merck Serono Nycomed 71 Diabetic Nephropathy 71 Announce Expiration 71 Enters Into Collaboration 71 intranasal formulation 71 Board Unanimously Rejects 71 R roscovitine CDK cyclin 71 motexafin gadolinium Injection 71 Veronate R 71 Begins Clinical Trial 71 phenyl salicylate methylene blue 71 Sumatriptan Succinate 71 Announces Discontinuation 71 Advanced Colorectal Cancer 71 Exherin 71 dihydrochloride Tablets 71 Controlled Trial 71 Placebo Controlled Trial 71 Mouse Models 71 Double Blind Placebo 71 Introduces Next Generation 71 Terminate Merger Agreement 71 DOR BioPharma Announces 71 Japanese Encephalitis Vaccine 71 brand ciclesonide HFA 71 ALVESCO ® 71 BIOTECHNOLOGY SOURCE 71 EVIZON TM 71 ERBITUX cetuximab 71 Panzem R 71 Drug Maker 71 Therapeutic Competitors 71 MKC# MKC# PP 71 COVIDIEN 71 non porcine pancreatic 71 personalized cellular immunotherapy 71 investigational pharmacologically unique 71 Lung Cancer Trial 71 Topline Results 71 include Phenoptin TM 71 Staphylococcus aureus Immune Globulin 71 topical antifungal product 71 Myelofibrosis 71 R memantine HCl 71 Advancing Drugs 71 Anti Inflammatory Drug 71 Sapacitabine 71 Boehringer Ingelheim MedImmune 71 Heart Transplant Recipients 71 Restructures Operations 71 Q1 Loss Narrows 71 Maribavir 71 Non Invasive Treatment 71 ® famotidine 71 Inc. www.micromet inc.com 71 ® lenalidomide 71 Clinical Outcome 71 Phase Ib Clinical Trial 71 ketoconazole USP Gel 71 rasagiline tablets 71 Preclinical Efficacy 71 XIAFLEX ® 71 markets XIFAXAN ® 71 TKB# 71 dextromethorphan quinidine 71 Genes Involved 71 Exercises Option 71 Interferon beta 1a 71 Secondary Hyperparathyroidism 71 Levoleucovorin 71 Angiotensin Converting Enzyme 71 R chorionic gonadotropin 71 Stem Cell Treatment 71 REG1 Anticoagulation System 71 Board Authorizes 71 GTC recombinant human 71 Diabetic Foot Ulcer 71 Parathyroid Hormone 71 IMPACS R 71 Weight Loss Drug 71 Inflammatory Arthritis 71 WRX STi +# mins 71 TELINTRA R 71 palonosetron hydrochloride Injection Dacogen 71 Bone Augmentation Material 71 Therapy Improves 71 Romidepsin 71 Nasdaq HALO 71 OTC BB PVCT 71 Equity Funds Declare 71 Prophylactic Treatment 71 Orphan Drug designations 71 Kidney Transplant Patients 71 Treat Anemia 71 LymphoStat B TM 71 Receives Favorable Ruling 71 Nitazoxanide 71 Paris IPN Euronext 71 sunitinib Sutent 71 Postmenopausal Osteoporosis 71 Infected Patients 71 oral proteasome inhibitor 71 please visit www.abraxane.com 71 FDA Approval 71 Medisorb ® 71 Kinase Inhibitors 71 BiovaxID TM 71 Potent Antiviral Activity 71 Disease IBD 71 MKC# MT 71 Gliadel R 71 Announce Commencement 71 Versus Placebo 71 Pharmacokinetics PK 71 ALTROPANE R 71 Invasive Fungal Infections 71 OTCBB IMUC 70 substantially excreted 70 Secures Additional 70 Naive Patients 70 Unanimously Recommends Approval 70 candidate deforolimus 70 FDA Warns 70 Regains Compliance 70 Invites Investors 70 METOZOLV TM ODT metoclopramide 70 Pharmaceuticals Initiates 70 Protein Linked 70 estrogen receptor beta agonist 70 Gonal f R 70 Recombinant Protein 70 Commercializes 70 Aeolus Pharmaceuticals Announces 70 Announces Favorable 70 Augment ™ 70 Diabetic Patients 70 Alfacell proprietary ribonuclease 70 Solution XOPENEX HFA 70 Sodium Sulfate Sodium Chloride 70 Synvisc ONE 70 Randomized Trials 70 Treating Chronic 70 PRICES GREAT DISCOUNTS 70 Treatment Shows Promise 70 Gastric Cancer 70 Ondansetron Injection USP 70 Nasdaq AVNC 70 oral nucleoside analogue 70 Pediatric Patients 70 novel proprietary KL4 70 Atypical Hemolytic Uremic Syndrome 70 Migraine Treatment 70 Chemotherapy Induced 70 Opterone R 70 Aliskiren 70 PRICE GREAT DISCOUNT FREE 70 Treatment Naïve Patients 70 Non Invasive 70 Develop Next Generation 70 Trodusquemine MSI 70 ANDA Filing 70 Albuferon TM 70 Therapeutic Potential 70 ergot derivatives 70 Boxed Warnings 70 Holds Promise 70 Pancreatic Adenocarcinoma 70 Factor Receptor 70 ORADUR ® 70 anti botulism antibody 70 Guidelines Recommend 70 hyaluronidase enzyme 70 Metabolic Disease 70 Introduces Breakthrough 70 Epidermal Growth Factor Receptor 70 ARRY # 70 PPD Declares 70 microRNA Therapeutics 70 Receives Approvals 70 Cardiovascular Prosthetic Devices 70 Showed Significant 70 J Am Acad 70 FEMALES SHOULD BE ADVISED 70 arsenic trioxide injection 70 NOVARTIS 70 Peginterferon 70 J Am Coll 70 TAXUS Element Paclitaxel Eluting 70 Demonstrated Significant 70 visit http:/www.mannkindcorp.com 70 mGluR5 negative 70 Crit Rev 70 Levels Linked 70 Orphan Designation 70 familial amyloidotic polyneuropathy FAP 70 Successfully Completed 70 Antiviral Drugs 70 Replacement Therapy 70 Oral Laquinimod 70 Anti CD# Antibody 70 Metformin HCl 70 Vaccine Shows Promise 70 investigational humanized monoclonal antibody 70 Intravitreal 70 Renal Impairment 70 NeutroPhase TM 70 Ebola Vaccine 70 Myriad logo BRACAnalysis 70 HuCAL PLATINUM R 70 Embolic Protection 70 Revises FY# Outlook 70 Predict Response 70 COMPLETES ACQUISITION OF 70 Shai Novik President 70 Multiple Myeloma Patients 70 Maven Semantic 70 Anemia Drug 70 Autologous Stem Cell Transplantation 70 Tramiprosate ALZHEMED TM 70 IIa Clinical Trial 70 prokinetic agent 70 Viagra Soft Cialis Soft 70 Breast Cancer Recurrence 70 DRRX 70 Bone Metastases 70 Atripla combines 70 Marketing Authorisation Application 70 Proc Am Soc 70 ADP receptor antagonist 70 Inflammatory Disease 70 label Lipofen R 70 bevacizumab Avastin R 70 CONTINUES LOWER 70 Drug Eluting Stent System 70 Bucindolol 70 Antithrombin 70 INDUSTRY ASSESSMENTS 70 mesylate tablets approved 70 Schizophrenia Treatment 70 Bepreve TM 70 Proves Successful 70 Metabolic Efficiency 70 telomerase therapeutic 70 Tesamorelin 70 Confirms Receipt 70 toenail onychomycosis 70 PSDV 70 Systemic Sclerosis 70 novel synthetic PEGylated 70 Demonstrate Significant 70 Genentech GlaxoSmithKline 70 Provides Shareholder 70 KL4 Surfactant 70 Phase 2a Study 70 Clinical Efficacy 70 Secures Funding 70 Orally administered 70 Tibotec Therapeutics division 70 Receives Approval From 70 RANK Ligand inhibitor 70 GNSZ 70 Statistically Significant 70 DP VPA 70 Strengthens Balance Sheet 70 Shingles Vaccine 70 Completes Tender Offer 70 Updates Guidance 70 visit www.genenews.com 70 somatropin Kuvan R 70 Recurrent Breast Cancer 70 Introduces Revolutionary 70 CD# CEA 70 Nucleoside 70 Brain Metastases 70 Launches Next Generation 70 Nasdaq PGNX 70 Dry Powder Inhalers 70 Paliperidone Palmitate 70 Q2 Loss Narrows 70 FDA Approvable Letter 70 CYP#A# CYP#D# 70 includes Dideco CarboMedics 70 Mutually Agree 70 including thyroiditis RA 70 REPRONEX ® menotropins 70 Generic Protonix 70 StaphVAX R 70 Regeneron Pharma 70 Liposomal 70 FS Antihemophilic Factor Recombinant 70 Study Shows Promise 70 Trastuzumab DM1 70 nasal calcitonin product 70 Postmenopausal Women 70 Enters Agreement 70 Dose Finding 70 Minimally Invasive Treatment 70 HCl PEPCID ® famotidine 70 Reports Receipt 70 NUEDEXTA ™ 70 IL# PE#QQR 70 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 70 DARA logo 70 Roche Boniva 70 Novel Anti Inflammatory 70 R brand levalbuterol 70 Chronic Lymphocytic Leukemia CLL 70 sodium sulfate sodium chloride